Patient costs in anticoagulation management: a comparison of primary and secondary care.

摘要: BACKGROUND: The demand for anticoagulation management is increasing. This has led to care being provided in non-hospital settings. While clinical studies have similarly demonstrated good these settings, it still unclear as which alternative the most efficient. AIM: To determine costs borne by patients when attending an clinic either primary or secondary and use this information consider cost-effectiveness of care, both from National Health Service patient perspectives. DESIGN OF STUDY: Observational study comparing two cohorts currently clinics. SETTING: Four clinics Birmingham one Warwickshire, haematology at University Hospitals Trust City Hospital NHS Trust. METHOD: survey was used ascertain costs. then conjunction with findings a recent randomised controlled trial establish cost-effectiveness. RESULTS: Patient were lower than settings; mean (standard deviation) per visit Pound Sterling6.78 (Pound Sterling5.04) versus Sterling14.58 Sterling9.08). previous analysis health sector perspective alone found higher cost adoption societal lead marked change result: similar total sectors. CONCLUSION: There are significantly also demonstrates that adopted economic evaluation can influence final result.